591 related articles for article (PubMed ID: 23676106)
61. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
[TBL] [Abstract][Full Text] [Related]
62. Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome.
Ortega-González C; Luna S; Hernández L; Crespo G; Aguayo P; Arteaga-Troncoso G; Parra A
J Clin Endocrinol Metab; 2005 Mar; 90(3):1360-5. PubMed ID: 15598674
[TBL] [Abstract][Full Text] [Related]
63. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
Diamanti-Kandarakis E; Kouli CR; Bergiele AT; Filandra FA; Tsianateli TC; Spina GG; Zapanti ED; Bartzis MI
J Clin Endocrinol Metab; 1999 Nov; 84(11):4006-11. PubMed ID: 10566641
[TBL] [Abstract][Full Text] [Related]
64. A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome.
Wei W; Zhao H; Wang A; Sui M; Liang K; Deng H; Ma Y; Zhang Y; Zhang H; Guan Y
Eur J Endocrinol; 2012 Jan; 166(1):99-105. PubMed ID: 22019891
[TBL] [Abstract][Full Text] [Related]
65. [Effect of Qingre Yangyin Recipe on Endocrine and Metabolism of Polycystic Ovary Syndrome Patients].
Zhang T
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Oct; 35(10):1175-80. PubMed ID: 26677666
[TBL] [Abstract][Full Text] [Related]
66. Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study.
Morin-Papunen L; Vauhkonen I; Koivunen R; Ruokonen A; Martikainen H; Tapanainen JS
J Clin Endocrinol Metab; 2003 Jan; 88(1):148-56. PubMed ID: 12519844
[TBL] [Abstract][Full Text] [Related]
67. [BO's abdominal acupuncture for obese type-2 diabetes mellitus].
Yang Y; Liu Y
Zhongguo Zhen Jiu; 2015 Apr; 35(4):330-4. PubMed ID: 26054139
[TBL] [Abstract][Full Text] [Related]
68. Comparison of Androgen Levels, Endocrine and Metabolic Indices, and Clinical Findings in Women with Polycystic Ovary Syndrome in Uygur and Han Ethnic Groups from Xinjiang Province in China.
Zhao H; Song X; Zhang L; Xu Y; Wang X
Med Sci Monit; 2018 Sep; 24():6774-6780. PubMed ID: 30252834
[TBL] [Abstract][Full Text] [Related]
69. [Study on the correlation between different Chinese medicine syndrome types and endocrine metabolism of polycystic ovarian syndrome].
Wang XJ; Zeng XL; Liu Y
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Aug; 31(8):1085-9. PubMed ID: 21910340
[TBL] [Abstract][Full Text] [Related]
70. Increased follistatin levels after oral contraceptive treatment in obese and non-obese women with polycystic ovary syndrome.
Chen MJ; Yang WS; Chen HF; Kuo JJ; Ho HN; Yang YS; Chen SU
Hum Reprod; 2010 Mar; 25(3):779-85. PubMed ID: 20093255
[TBL] [Abstract][Full Text] [Related]
71. Effect of lifestyle modification and metformin therapy on emerging cardiovascular risk factors in overweight Indian women with polycystic ovary syndrome.
Rajagopal G; Reddy AP; Venkata Harinarayan C; Suresh V; Bitla A; P V L N Rao S; Sachan A
Metab Syndr Relat Disord; 2012 Aug; 10(4):273-9. PubMed ID: 22468948
[TBL] [Abstract][Full Text] [Related]
72. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
Ardawi MS; Rouzi AA
Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
[TBL] [Abstract][Full Text] [Related]
73. Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters.
Pirwany IR; Fleming R; Greer IA; Packard CJ; Sattar N
Clin Endocrinol (Oxf); 2001 Apr; 54(4):447-53. PubMed ID: 11318779
[TBL] [Abstract][Full Text] [Related]
74. The Predictive Role of Serum Cystatin C Levels in Polycystic Ovary Syndrome in Adolescents.
Çınar M; Aksoy RT; Güzel Aİ; Tokmak A; Çandar T; Taşçı Y
J Pediatr Adolesc Gynecol; 2016 Aug; 29(4):353-6. PubMed ID: 26740281
[TBL] [Abstract][Full Text] [Related]
75. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.
Ciaraldi TP; Aroda V; Mudaliar SR; Henry RR
Metabolism; 2013 Nov; 62(11):1587-96. PubMed ID: 23958241
[TBL] [Abstract][Full Text] [Related]
76. [Advantages of Chinese medicine for treatment of blood sugar and lipid metabolic disorders in patients with polycystic ovarian syndrome].
Zhao H; Bao WF; Zhang T
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Jul; 29(7):595-8. PubMed ID: 19852289
[TBL] [Abstract][Full Text] [Related]
77. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.
Diamanti-Kandarakis E; Katsikis I; Piperi C; Alexandraki K; Panidis D
Clin Endocrinol (Oxf); 2007 Jan; 66(1):103-9. PubMed ID: 17201808
[TBL] [Abstract][Full Text] [Related]
78. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.
Ducluzeau PH; Cousin P; Malvoisin E; Bornet H; Vidal H; Laville M; Pugeat M
J Clin Endocrinol Metab; 2003 Aug; 88(8):3626-31. PubMed ID: 12915646
[TBL] [Abstract][Full Text] [Related]
79. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
[TBL] [Abstract][Full Text] [Related]
80. The effect of alfacalcidiol and metformin on metabolic disturbances in women with polycystic ovary syndrome.
Figurová J; Dravecká I; Petríková J; Javorský M; Lazúrová I
Horm Mol Biol Clin Investig; 2017 Mar; 29(3):85-91. PubMed ID: 28157691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
